Dalian Bio-Chem Co Ltd (SHG:603360) — Market Cap & Net Worth
Market Cap & Net Worth: Dalian Bio-Chem Co Ltd (603360)
Dalian Bio-Chem Co Ltd (SHG:603360) has a market capitalization of $2.27 Billion (CN¥15.48 Billion) as of May 7, 2026. Listed on the SHG stock exchange, this China-based company holds position #5867 globally and #1253 in its home market, demonstrating a -6.76% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Dalian Bio-Chem Co Ltd's stock price CN¥21.92 by its total outstanding shares 706223654 (706.22 Million). Analyse cash efficiency ratio of Dalian Bio-Chem Co Ltd to see how efficiently the company converts income to cash.
Dalian Bio-Chem Co Ltd Market Cap History: 2017 to 2026
Dalian Bio-Chem Co Ltd's market capitalization history from 2017 to 2026. Data shows growth from $676.70 Million to $2.27 Billion (19.16% CAGR).
Dalian Bio-Chem Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Dalian Bio-Chem Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.75x
Dalian Bio-Chem Co Ltd's market cap is 1.75 times its annual revenue
Latest Price to Earnings (P/E) Ratio
6.66x
Dalian Bio-Chem Co Ltd's market cap is 6.66 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $676.70 Million | $410.36 Million | $100.27 Million | 1.65x | 6.75x |
| 2018 | $557.02 Million | $528.17 Million | $145.19 Million | 1.05x | 3.84x |
| 2019 | $1.60 Billion | $871.90 Million | $306.80 Million | 1.83x | 5.20x |
| 2020 | $1.00 Billion | $749.54 Million | $221.75 Million | 1.34x | 4.53x |
| 2021 | $893.46 Million | $1.01 Billion | $250.49 Million | 0.89x | 3.57x |
| 2022 | $1.20 Billion | $1.26 Billion | $402.57 Million | 0.96x | 2.99x |
| 2023 | $1.09 Billion | $1.07 Billion | $328.38 Million | 1.03x | 3.33x |
| 2024 | $2.30 Billion | $1.31 Billion | $345.26 Million | 1.75x | 6.66x |
Competitor Companies of 603360 by Market Capitalization
Companies near Dalian Bio-Chem Co Ltd in the global market cap rankings as of May 7, 2026.
Key companies related to Dalian Bio-Chem Co Ltd by market ranking:
- Linde plc Ordinary Shares (NASDAQ:LIN): Ranked #93 globally with a market cap of $210.18 Billion USD.
- Air Liquide SA (PA:AI): Ranked #225 globally with a market cap of $108.00 Billion USD ( €92.38 Billion EUR).
- AIR LIQUIDE ADR 1/5/EO 11 (F:AILA): Ranked #233 globally with a market cap of $103.86 Billion USD ( €88.84 Billion EUR).
- Sherwin-Williams Co (NYSE:SHW): Ranked #321 globally with a market cap of $80.23 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #93 | Linde plc Ordinary Shares | NASDAQ:LIN | $210.18 Billion | $501.87 |
| #225 | Air Liquide SA | PA:AI | $108.00 Billion | €180.28 |
| #233 | AIR LIQUIDE ADR 1/5/EO 11 | F:AILA | $103.86 Billion | €36.60 |
| #321 | Sherwin-Williams Co | NYSE:SHW | $80.23 Billion | $323.63 |
Dalian Bio-Chem Co Ltd Historical Marketcap From 2017 to 2026
Between 2017 and today, Dalian Bio-Chem Co Ltd's market cap moved from $676.70 Million to $ 2.27 Billion, with a yearly change of 19.16%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥2.27 Billion | -31.97% |
| 2025 | CN¥3.33 Billion | +44.81% |
| 2024 | CN¥2.30 Billion | +110.50% |
| 2023 | CN¥1.09 Billion | -9.26% |
| 2022 | CN¥1.20 Billion | +34.74% |
| 2021 | CN¥893.46 Million | -11.07% |
| 2020 | CN¥1.00 Billion | -37.04% |
| 2019 | CN¥1.60 Billion | +186.50% |
| 2018 | CN¥557.02 Million | -17.69% |
| 2017 | CN¥676.70 Million | -- |
End of Day Market Cap According to Different Sources
On May 7th, 2026 the market cap of Dalian Bio-Chem Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.27 Billion USD |
| MoneyControl | $2.27 Billion USD |
| MarketWatch | $2.27 Billion USD |
| marketcap.company | $2.27 Billion USD |
| Reuters | $2.27 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Dalian Bio-Chem Co Ltd
Dalian BIO-CHEM Company Limited researches, develops, produces, and sells industrial fungicides in China and internationally. It offers various isothiazolinone fungicides, including CMIT/MIT, MIT, OIT, DCOIT, and BIT series products; and OEM/ODM services. The company was founded in 2003 and is headquartered in Dalian, China.